Skip to content
drillr.ai
Sign up

CEROW

CERo Therapeutics Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−26.92%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue1.1M1.1M1.2M1.1M—
Gross Profit(1.1M)(1.1M)(1.2M)(1.1M)—
Operating Expenses
R&D Expense9.8M10.4M6.3M5.3M9.8M
SG&A Expense8.4M8.1M9.0M2.9M2.8M
General & Admin Expense8.4M8.1M9.0M2.9K2.1M
Selling & Marketing Expense———2.9M715.8K
Other Expenses(668.8K)(1.1M)351.0040.0K(9.8M)
Total Operating Expenses17.5M17.4M15.3M2.9M2.9M
Cost and Expenses18.4M18.5M15.3M2.9M2.9M
Operating Income (EBIT)(18.4M)(18.5M)(15.3M)(2.9M)(2.9M)
Non-Operating
Interest Income13.9K11.6K26.7K138.3K2.8M
Interest Expense166.3K————
Net Interest Income(152.4K)11.6K26.7K138.3K2.8M
Other Non-Op Income/Expense(2.3M)(1.5M)7.6M491.6K2.8M
Non-Operating Income (excl Interest)707.3K—(7.6M)(491.6K)—
EBT (Pre-Tax Income)(20.7M)(19.9M)(7.7M)(2.4M)(68.6K)
Income Tax Expense———94.8K599.2K
Bottom Line
Net Income(20.7M)(19.9M)(7.7M)(2.5K)(667.7K)
Earnings from Cont. Ops(20.7M)(19.9M)(7.7M)(2.5M)(667.7K)
Earnings from Discont. Ops—————
Bottom Line Net Income(96.0M)(95.5M)(10.5M)(2.5M)(667.7K)
Per Share
Basic EPS($73.31)($22.58)($6.87)($2,497.20)($19.73)
Diluted EPS($73.31)($22.58)($6.87)($2,497.20)($19.73)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding28.8M4.2M12079473537353
Diluted Shares Outstanding28.8M4.2M12079473537353
Profitability Metrics
EBITDA(18.0M)(17.4M)(6.6M)(2.4M)(68.6K)
D&A1.1M1.1M1.2M2.9K2.9M
EBIT(19.1M)(18.5M)(7.7M)(2.4M)(2.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026